ICON plc (ICLR)
182.99
-0.79
(-0.43%)
USD |
NASDAQ |
Oct 27, 13:10
ICON Enterprise Value : 16.78B for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 16.78B |
| October 23, 2026 | 16.89B |
| October 22, 2026 | 16.90B |
| October 21, 2026 | 16.89B |
| October 20, 2026 | 16.04B |
| October 19, 2026 | 15.57B |
| October 16, 2026 | 15.73B |
| October 15, 2026 | 16.11B |
| October 14, 2026 | 15.63B |
| October 13, 2026 | 15.28B |
| October 12, 2026 | 15.28B |
| October 09, 2026 | 15.26B |
| October 08, 2026 | 15.29B |
| October 07, 2026 | 15.26B |
| October 06, 2026 | 15.07B |
| October 05, 2026 | 15.58B |
| October 02, 2026 | 15.10B |
| October 01, 2026 | 15.08B |
| September 30, 2026 | 15.71B |
| September 29, 2026 | 15.74B |
| September 28, 2026 | 16.14B |
| September 25, 2026 | 15.89B |
| September 24, 2026 | 16.01B |
| September 23, 2026 | 15.24B |
| September 22, 2026 | 15.49B |
| Date | Value |
|---|---|
| September 21, 2026 | 15.68B |
| September 18, 2026 | 15.26B |
| September 17, 2026 | 15.69B |
| September 16, 2026 | 16.02B |
| September 15, 2026 | 15.90B |
| September 14, 2026 | 15.63B |
| September 11, 2026 | 15.66B |
| September 10, 2026 | 15.38B |
| September 09, 2026 | 14.90B |
| September 08, 2026 | 14.81B |
| September 04, 2026 | 15.32B |
| September 03, 2026 | 15.22B |
| September 02, 2026 | 14.93B |
| September 01, 2026 | 15.05B |
| August 31, 2026 | 15.33B |
| August 28, 2026 | 15.72B |
| August 27, 2026 | 15.69B |
| August 26, 2026 | 15.63B |
| August 25, 2026 | 15.63B |
| August 24, 2026 | 15.98B |
| August 21, 2026 | 15.89B |
| August 20, 2026 | 16.04B |
| August 19, 2026 | 15.91B |
| August 18, 2026 | 15.49B |
| August 17, 2026 | 15.67B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 59.33B |
| Medpace Holdings, Inc. | 18.35B |
| Proteome Sciences Plc | -- |
| Champions Oncology, Inc. | 74.82M |
| Avantor, Inc. | 15.09B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 72.58M |
| Revenue (Quarterly) | 2.063B |
| Total Expenses (Quarterly) | 1.991B |
| EPS Diluted (Quarterly) | 0.9381 |
| Gross Profit Margin (Quarterly) | 18.83% |
| Profit Margin (Quarterly) | 3.52% |
| Earnings Yield | 0.30% |
| Operating Earnings Yield | 5.95% |
| Normalized Earnings Yield | 2.832 |